BALF_logo_2014_white_blue bckgd_vertical.png
Bay Area Lyme Foundation Selects National Winner of the 2024 Emerging Leader Award for Research of Combination Therapies to Treat Chronic Lyme Disease
August 01, 2024 11:00 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces the recipient of the 2024 Emerging Leader Award...
60Degrees_logo_RGB_Logo.jpg
60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment
July 09, 2024 06:31 ET | Sixty Degrees Pharmaceuticals
60 Degrees Pharma wins IRB approval for tafenoquine study for treating persistent babesiosis in immunocompromised patients despite prior treatment.
60Degrees_logo_RGB_Logo.jpg
First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind
June 27, 2024 07:59 ET | Sixty Degrees Pharmaceuticals
60 Degrees Pharmaceuticals enrolls first patient in a clinical study at Tufts to assess safety and efficacy of tafenoquine in treating acute babesiosis.
60Degrees_logo_RGB_Logo.jpg
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
May 30, 2024 07:59 ET | Sixty Degrees Pharmaceuticals
60 Degrees Pharmaceuticals to start the first clinical trial of tafenoquine for babesiosis at Tufts Medical Center. Enrollment begins June 13, 2024.
BALF_logo_2014_white_blue bckgd_vertical.png
Twin Cities Lyme Foundation and Bay Area Lyme Foundation Unite Efforts to Further Advance the Fight Against Tick-Borne Diseases
May 29, 2024 11:00 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced it has united efforts with Twin Cities Lyme...
BALF_logo_2014_white_blue bckgd_vertical.png
New Discovery Identifies “Don’t Eat Me” Protein that Allows Lyme Bacteria to Evade Body’s Immune Response
May 07, 2024 11:01 ET | Bay Area Lyme Foundation
PALO ALTO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced a study finding a new mechanism of immune...
BALF_logo_2014_white_blue bckgd_vertical.png
UPDATE - New Study Reveals Potential Treatment for Neurological Lyme Disease
April 19, 2024 12:45 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study...
BALF_logo_2014_white_blue bckgd_vertical.png
 New Study Reveals Potential Treatment for Neurological Lyme Disease
April 18, 2024 11:00 ET | Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study showing...
LSU Researchers' Noo
LSU Researchers' Nootkatone Studies Could Lead to Prevention of Lyme Disease
April 09, 2024 10:00 ET | LSU College of Engineering
BATON ROUGE, La., April 09, 2024 (GLOBE NEWSWIRE) -- Thanks to a $550,000 National Science Foundation Partnership for Innovation grant—the largest NSF PFI grant ever awarded to LSU—LSU Chemical...
HelixBind_Logo_AS2-no BG (2018).png
HelixBind Named a Phase 2 Winner of the LymeX Diagnostics Prize by HHS and Steven & Alexandra Cohen Foundation
February 07, 2024 11:05 ET | HelixBind
HelixBind Named a Phase 2 Winner of the LymeX Diagnostics Prize by HHS and Steven & Alexandra Cohen Foundation